CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study) Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines The year in cardiovascular medicine 2020: interventional cardiology Prospective Elimination of Distal Coronary Sinus to Left Atrial Connection for Atrial Fibrillation Ablation (PRECAF) Randomized Controlled Trial Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT
|<<... 13 14 15 16 17 18 19 ...>>|

Original Research2018 Aug 27.

JOURNAL：N Engl J Med. Article Link

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

Obadia JF, Messika-Zeitoun D, MITRA-FR Investigators et al. Keywords: chronic heart failure; reduced left ventricular ejection fraction; severe secondary mitral-valve regurgitation; percutaneous mitral-valve repair;clinical outcome

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top